ÂÜÀòÂÒÂ×

Mark Fridlyand

Director, Strategy & Corporate Finance at Synonym Biotechnologies

Mark Fridlyand has a diverse work experience. Mark has served as the Director of Strategy & Corporate Development at Synonym since January 2022. Prior to this role, Mark worked at Knotel from February 2017 to October 2021, where they held a position in Strategy & Corporate Development. Mark also has experience in Financial Services Advisory at EY, where they worked from May 2014 to February 2017.

Mark Fridlyand attended The Russian Presidential Academy of National Economy and Public Administration (RANEPA) from 2009 to 2014, where they earned a Master's degree in Economics and Management.

Links

Previous companies

EY logo
Knotel logo